Alcon

Intersil CFO resigns

bizjournals.com
22 hrs ago 2 related
        

Silicon Valley / San Jose Business Journal said Wednesday that David Zinsner resigned from his position as senior vice president and chief financial officer to pursue another opportunity. Milpitas-based Intersil (NASDAQ:ISIL)...

add comment
yahoo.com: Reuters Deals Today yahoo.com

Europe approves Alcon's Azarga glaucoma treatment

finanznachrichten.de
yesterday 5 related
        

ZURICH, Dec 3 (Reuters) - The European Medicines Agency has approved Alcon Inc' s glaucoma treatment Azarga, the eye-care products maker said on Wednesday. Although expected, after a recommendation in September, the news...

add comment

Intersil Announces the Resignation of David Zinsner, Chief Financial Officer

tmcnet.com
yesterday 6 related
        

MILPITAS, CA, December 3 / MARKET WIRE/ -- Intersil Corporation (NASDAQ: ISIL), a world leader in the design and manufacture of high-performance analog semiconductors, today announced that David Zinsner has resigned from his...

add comment
                   

Alcon Announces AZARGA® Ophthalmic Suspension Approved for Treatment of Patients with Glaucoma or...

finanzen.net
yesterday 5 related
        

Alcon, Inc. (NYSE:ACL) announced today that the European Medicines Agency (EMEA) has approved Alcon’s fixed combination eye drop, AZARGA® (brinzolamide 10mg/ml+timolol 5mg/ml) ophthalmic suspension, for ...

add comment

Mentor (MNT) Agrees To Be Acquired By Johnson & Johnson (JNJ) for $31/Share

pharmiweb.co.uk
01-Dec-2008 133 related
        

Johnson & Johnson (JNJ) volatility Elevated at 41; JNJ's $1.07B purchase of MNT to be EPS dilutive Mentor (MNT) volatility Elevated; JNJ buying MNT for $1.07 billion cash More News related to Mergers and Acquisitions Wachovia...

add comment
                   

Wachovia Upgrades Alcon (ACL) to Outperform, Strong Chance Company Acquired by Novartis (NVS)

pharmiweb.co.uk
01-Dec-2008
        

More News related to Upgrades More News related to Upgrades Wachovia upgrades Alcon (NYSE: ACL) to Outperform. Wachovia analyst says, "ACL's stock has retreated and valuation is reasonable, in our view. Since late October, the...

add comment

Alcon upgraded by Wachovia (Briefing.com)

yahoo.com
01-Dec-2008 15 related
        

To learn more about Yahoo!'s use of personal information, please read the Privacy Policy. Analyst Summary Information (upgrades/downgrades module) provided by Briefing.com. All information provided "as is" for informational...

add comment

ScientistI-MedicinalChemistry

preferredjobs.com
01-Dec-2008 3 related
        

Alcon is the world`s leading eye care company with sales of $5.6 billion. The company`s nearly 15,000 employees worldwide, work in 75 facilities around the world to research, develop, manufacture and sell our products in more...

add comment
                   

India's Jews stunned by Mumbai attack (AFP)

yahoo.com
30-Nov-2008 21 related
        

MUMBAI (AFP) - They are a tiny, scattered and low-profile community of just a few thousand among a population of 1.1 billion, so India's Jews were at a loss to explain why they were targeted in the Mumbai attacks.

add comment

UPDATE 2-Novartis might up dividend in future- CEO tells TV

pharmiweb.co.uk
28-Nov-2008
        

ZURICH, Nov 28 (Reuters) - Novartis AG could increase its dividend and also resume share buybacks once it has reduced its debt, the head of the Swiss drugmaker said in an interview published on Friday. "I assume that we will...

add comment
1 2 3 4 5 next »